Wedbush Maintains Neutral on Cerence, Raises Price Target to $21
Portfolio Pulse from Benzinga Newsdesk
Wedbush analyst Daniel Ives maintains a Neutral rating on Cerence (NASDAQ:CRNC) and raises the price target from $19 to $21.

February 07, 2024 | 1:39 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Wedbush analyst Daniel Ives maintains a Neutral rating on Cerence but raises the price target from $19 to $21.
The increase in price target from $19 to $21 by a reputable analyst suggests a positive outlook on the stock's value, potentially leading to short-term price appreciation. However, the Neutral rating indicates that the analyst sees limited upside beyond the new target, balancing the impact.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100